Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever

References

• Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006;6:203–14.
   PubMed Web of Science ®Google Scholar
• Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11(Suppl 4):S794–800.
   Google Scholar
• Kraus AA, Mirazimi A. Molecular biology and pathogenesis of Crimean–Congo hemorrhagic fever virus. Future Virol 2010;5:469–79.
   Web of Science ®Google Scholar
• Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999;18:6853–66.
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994;10:405–55.
   PubMedGoogle Scholar
• Heron E, Deloukas P, Van Loon AP. The complete exon–intron structure of the 150 kb human gene NFKB1, which encodes p105 and p50 proteins of transcription factors NF kappa B and I-kappa B gamma: implications for NF-kappa B-mediated signal transduction. Genomics 1995;30:493–507.
   PubMed Web of Science ®Google Scholar
• Karban AS, Okazaki T, Panhuysen CI, Gallegos T, Potter JJ, Bailey-Wilson JE, . Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum Mol Genet 2004;3:35–45.
   Google Scholar
• Le Beau MM, Ito C, Cogswell P, Espinosa R, Fernald AA, Baldwin AS. Chromosomal localization of the genes encoding the p50/p105 subunits of NF-kappa B (NFKB2) and the I kappa B/MAD-3 (NFKBI) inhibitor of NF-kappa B to 4q24 and 14q13, respectively. Genomics 1992;14:529–31.
   PubMedGoogle Scholar
• Chiao PJ, Miyamoto S, Verma IM. Autoregulation of IκBα activity. Proc Natl Acad Sci U S A 1994;91:28–32.
   PubMed Web of Science ®Google Scholar
• Hiscott J, Kwon H, Genin P. Hostile takeovers: viral appropriation of the NF-κB pathway. J Clin Invest 2001;107: 143–151.
   PubMed Web of Science ®Google Scholar
• Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S, Zupanc TA. Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. Clin Vaccine Immunol 2010;17:1086–93.
   PubMedGoogle Scholar
• Bodur H, Akinci E, Onguru P, Uyar Y, Basturk B, Göze MG. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int J Infect Dis 2010;14:704–7.
   Web of Science ®Google Scholar
• Connolly-Andersen AM, Moll G, Andersson C, Akerström S, Karlberg H, Douagi I, . Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol 2011;85:7766–74.
   PubMed Web of Science ®Google Scholar
• Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006;36:272–6.
   PubMed Web of Science ®Google Scholar
• Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941–4.
   PubMed Web of Science ®Google Scholar
• Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007;22:1387–98.
   PubMed Web of Science ®Google Scholar
• Zhang GL, Zou YF, Feng XL. Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Inflamm Res 2010;60:11–8.
   PubMedGoogle Scholar
• Tuncay SŞ, Okyay P, Bardakci F. Identification of NF-κB1 and NF-κBIA polymorphisms using PCR–RFLP assay in a Turkish population. Biochem Genet 2010;48:104–12.
   PubMedGoogle Scholar
• Yeh FC, Yang RC, Boyle T. POPGENE, version 1.31: Microsoft Window-based freeware for population genetic analysis. University of Alberta; 1999. Available at: http://www.ualberta.ca/fyer (accessed 2010).
   Google Scholar
• Gunes T, Engin A, Poyraz O. Crimean-Congo hemorrhagic fever virus in high-risk population, Turkey. Emerg Infect Dis 2009;15:461–4.
   PubMedGoogle Scholar
• Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002;3:221–7.
   PubMed Web of Science ®Google Scholar
• Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol 2002;2:725–34.
   PubMed Web of Science ®Google Scholar
• Orozco G, Sanchez E, Collado MD, Lopez-Nevot MA, Paco L, Garcia A, . Analysis of the functional NFKB1 promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Tissue Antigens 2005;65:183–6.
   PubMedGoogle Scholar
• Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, . Association of NFKB1 –94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves’ disease. Genes Immun 2007;8: 532–5.
   PubMed Web of Science ®Google Scholar
• Lin CH, Ou TT, Wu CC, Tsai WC, Liu HW, Yen JH. IκBα promoter polymorphisms in patients with rheumatoid arthritis. Int J Immunogenet 2007;34:51–4.
   PubMedGoogle Scholar
• Engin A, Arslan S, Kızıldağ S, Öztük H, Elaldı N, Dökmetaş I , . Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect 2010;12:1071–8.
   PubMed Web of Science ®Google Scholar
• Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, . A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 2004; 19:153–6.
   PubMed Web of Science ®Google Scholar
• Curran JE, Weinstein SR, Griffiths LR. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer. Cancer Lett 2002;188:103–7.
   PubMed Web of Science ®Google Scholar
• Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, . NFκB and its inhibitor IκB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol 2006;67:706–13.
   PubMed Web of Science ®Google Scholar
• Gao J, Pfeifer D, He LJ, Qiao F, Zhang Z, Arbman G, . Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese population. Scand J Gastroenterol 2007;42:345–50.
   PubMed Web of Science ®Google Scholar
• Parker KM, Ma MH, Manyak S, Altamirano CV, Tang YM, Frantzen M, . Identification of polymorphisms of the IκBα gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet 2002;137:43–8.
   PubMedGoogle Scholar